Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences

Human Gene Therapy Methods

Volumn 23, Issue 1, 2012, Pages 18-28

  Aurnhammer, Christine ^a   Haase, Maren ^a   Muether, Nadine ^b   Hausl, Martin ^b   Rauschhuber, Christina ^b   Huber, Ingrid ^a   Nitschko, Hans ^b   Busch, Ulrich ^a   Sing, Andreas ^a   Ehrhardt, Anja ^b,c   Baiker, Armin ^a  

^a Bavarian Health and Food Safety Authority   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; PARVOVIRUS VECTOR; PLASMID VECTOR; PRIMER DNA; SINGLE STRANDED DNA;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS SEROTYPE 2; ARTICLE; CONTROLLED STUDY; GENE DOSAGE; HUMAN; INVERTED TERMINAL REPEAT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; WILD TYPE; GENE THERAPY; GENE VECTOR; GENETICS; LONG TERMINAL REPEAT; METABOLISM; METHODOLOGY; VIRUS CAPSID; VIRUS GENOME;

CAPSID; DEPENDOVIRUS; GENETIC THERAPY; GENETIC VECTORS; GENOME, VIRAL; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; TERMINAL REPEAT SEQUENCES;

EID: 84871997054     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2011.034     Document Type: Article

References (33)

1. Asokan, A. (2010). Reengineered AAV vectors: Old dog, new tricks. Discov. Med. 9, 399-403.
2. Astell, C.R., Thomson, M., Merchlinsky, M., and Ward, D.C. (1983). The complete DNA sequence of minute virus of mice, an autonomous parvovirus. Nucleic Acids Res. 11, 999-1018.
3. Atchison, R.W., Casto, B.C., and Hammon, W.M. (1965). Adenovirus-associated defective virus particles. Science 149, 754-756.
4. Bish, L.T., Morine, K., Sleeper, M.M., et al. (2008). Adenoassociated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum. Gene Ther. 19, 1359-1368.
5. Bustin, S.A., Benes, V., Garson, J.A., et al. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611-622.
6. Carter, B.J. (2005). Adeno-associated virus vectors in clinical trials. Hum. Gene Ther. 16, 541-550. (Pubitemid 40740922)
7. Choi, V.W., Samulski, R.J., and McCarty, D.M. (2005). Effects of adeno-associated virus DNA hairpin structure on recombination. J. Virol. 79, 6801-6807. (Pubitemid 40677312)
8. Daya, S., and Berns, K.I. (2008). Gene therapy using adenoassociated virus vectors. Clin. Microbiol. Rev. 21, 583-593.
9. Gao, G., Lu, Y., Calcedo, R., et al. (2006). Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol. Ther. 13, 77-87. (Pubitemid 41763485)
10. Goncalves, M.A. (2005). Adeno-associated virus: From defective virus to effective vector. Virol. J. 2, 43.
11. Grieger, J.C., Choi, V.W., and Samulski, R.J. (2006). Production and characterization of adeno-associated viral vectors. Nat. Protocols 1, 1412-1428.
12. Grimm, D., Kern, A., Pawlita, M., et al. (1999). Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2. Gene Ther. 6, 1322-1330. (Pubitemid 29359028)
13. Grimm, D., Pandey, K., and Kay, M.A. (2005). Adeno-associated virus vectors for short hairpin RNA expression. Methods Enzymol. 392, 381-405. (Pubitemid 40092527)
14. Heilbronn, R., Burkle, A., Stephan, S., and Zur Hausen, H. (1990). The adeno-associated virus rep gene suppresses herpes simplex virus-induced 1DNA amplification. J. Virol. 64, 3012-3018. (Pubitemid 20171293)
15. Knipe, D.M., and Howley, P.M. (2001). Fundamental Virology. (Lippincott Williams & Wilkins, Philadelphia, PA).
16. Laughlin, C.A., Tratschin, J.D., Coon, H., and Carter, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73.
17. Lusby, E., Fife, K.H., and Berns, K.I. (1980). Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J. Virol. 34, 402-409. (Pubitemid 10104041)
18. Mayor, H.D., Torikai, K., Melnick, J.L., and Mandel, M. (1969). Plus and minus single-stranded DNA separately encapsidated in adeno-associated satellite virions. Science 166, 1280-1282.
19. McAlister, V.J., and Owens, R.A. (2007). Preferential integration of adeno-associated virus type 2 into a polypyrimidine/polypurine-rich region within AAVS1. J. Virol. 81, 9718-9726. (Pubitemid 350067676)
20. McCarty, D.M., Fu, H., Monahan, P.E., et al. (2003). Adenoassociated virus terminal repeat (TR) mutant generates selfcomplementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 10, 2112-2118. (Pubitemid 37536760)
21. Mitchell, A.M., Nicolson, S.C., Warischalk, J.K., and Samulski, R.J. (2010). AAV's anatomy: Roadmap for optimizing vectors for translational success. Curr. Gene Ther. 10, 319-340.
22. Monahan, P.E., and Samulski, R.J. (2000). Adeno-associated virus vectors for gene therapy: More pros than cons? Mol. Med. Today 6, 433-440.
23. Monahan, P.E., Jooss, K., and Sands, M.S. (2002). Safety of adeno-associated virus gene therapy vectors: A current evaluation. Expert Opin. Drug Safety 1, 79-91.
24. Rohr, U.P., Wulf, M.A., Stahn, S., et al. (2002). Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J. Virol. Methods 106, 81-88. (Pubitemid 35279652)
25. Samulski, R.J., Chang, L.S., and Shenk, T. (1987). A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096-3101. (Pubitemid 17131491)
26. Sonntag, F., Schmidt, K., and Kleinschmidt, J.A. (2010). A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc. Natl. Acad. Sci. U.S.A. 107, 10220-10225.
27. Srivastava, A., Lusby, E.W., and Berns, K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564. (Pubitemid 13225420)
28. Thomas, C.E., Storm, T.A., Huang, Z., and Kay, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78, 3110-3122. (Pubitemid 38314369)
29. Wang, J., Faust, S.M., and Rabinowitz, J.E. (2011). The next step in gene delivery: Molecular engineering of adeno-associated virus serotypes. J. Mol. Cell. Cardiol. 50, 793-802.
30. Wang, Z., Ma, H.I., Li, J., et al. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111. (Pubitemid 37536759)
31. Wobus, C.E., Hugle-Dorr, B., Girod, A., et al. (2000). Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 74, 9281-9293.
32. Yan, Z., Zak, R., Zhang, Y., and Engelhardt, J.F. (2005). Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes. J. Virol. 79, 364-379. (Pubitemid 39648390)
33. Yang, C.C., Xiao, X., Zhu, X., et al. (1997). Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71, 9231-9247. (Pubitemid 27492365)